Global initiative for chronic obstructive lung disease (GOLD) 2022 report was released on
November 15, 2021. In general, chronic obstructive pulmonary disease (COPD) diagnosis …

Rationale: Guidelines recommend inhaled corticosteroids (ICS) for patients with chronic
obstructive pulmonary disease (COPD) and select indications, including asthma history …

Introduction Chronic obstructive pulmonary disease (COPD) is the third most common cause
of death worldwide and 24% of the patients die within 5 years of diagnosis. Areas Covered …

World COPD Day raises awareness about chronic obstructive pulmonary disease (COPD).
COPD accounts for over 150,000 US deaths per year. A major challenge is that COPD …

There have been an estimated 100 million people diagnosed with COVID-19 in the United
States, with a majority of patients reporting persistent symptoms expressed as long COVID …

Within just a few months, SARS-CoV-2 has evolved from a virtually unknown pathogen to a
leading cause of morbidity and mortality worldwide. As COVID-19 infection can affect …

Introduction Many adults hospitalised with COVID-19 have persistent symptoms such as
fatigue, breathlessness and brain fog that limit day-to-day activities. These symptoms can …

La nueva edición de 2021 de la Guía Española de la EPOC (GesEPOC 2021) propone,
junto al tratamiento farmacológico ajustado por estratificación de riesgo y fenotipo, el …

Background Data on the post-acute and post-infectious complications of patients who have
recovered from severe coronavirus disease 2019 (COVID-19) are limited. While studies …

Background Body composition measures, specifically low weight or reduced muscle mass,
are associated with mortality in COPD, but the effect of longitudinal body composition …